Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2015
Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
Rosalind A Eeles, James P Morden, Martin Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2002
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
Jean-Yves Douillard, Paulo M Hoff, Jamey R Skillings, et al.
BJU International
|
October 30, 2020
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot
Sarah Spencer-Bowdage, Beth Russell, Jeannie Rigby, et al.
BJUI Compass
|
August 10, 2022
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic
Beth Russell, Sarah Spencer-Bowdage, Jeannie Rigby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial
Alain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene
Srinivasan Madhusudan, Ayala Tamir, Nicholas Bates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2010
Amplification of epidermal growth factor receptor gene in renal cell carcinoma
Iman El-Hariry, Thomas Powles, Mike R Lau, et al.
Breast Cancer Research and Treatment
|
January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
Nicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
Human Molecular Genetics
|
April 25, 2002
Mutations in TITF-1 are associated with benign hereditary chorea
Guido J Breedveld, Jeroen W F van Dongen, Cesare Danesino, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2015
Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
Rosalind A Eeles, James P Morden, Martin Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2002
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
Jean-Yves Douillard, Paulo M Hoff, Jamey R Skillings, et al.
BJU International
|
October 30, 2020
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot
Sarah Spencer-Bowdage, Beth Russell, Jeannie Rigby, et al.
BJUI Compass
|
August 10, 2022
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic
Beth Russell, Sarah Spencer-Bowdage, Jeannie Rigby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial
Alain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene
Srinivasan Madhusudan, Ayala Tamir, Nicholas Bates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2010
Amplification of epidermal growth factor receptor gene in renal cell carcinoma
Iman El-Hariry, Thomas Powles, Mike R Lau, et al.
Breast Cancer Research and Treatment
|
January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
Nicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
Human Molecular Genetics
|
April 25, 2002
Mutations in TITF-1 are associated with benign hereditary chorea
Guido J Breedveld, Jeroen W F van Dongen, Cesare Danesino, et al.
Page
of 5